Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Baeza-Garza CD"'
Autor:
Arndt, S, Baeza-Garza, CD, Logan, A, Rosa, T, Wedmann, R, Prime, TA, Martin, JL, Saeb-Parsy, K, Krieg, T, Filipovic, MR, Hartley, RC, Murphy, MP
Hydrogen sulfide (H$_{2}$S) is produced endogenously in vivo and has multiple effects on signaling pathways and cell function. Mitochondria can be both an H$_{2}$S source and sink, and many of the biological effects of H$_{2}$S relate to its interact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62df649df33511d428095c5f0baa601c
Autor:
Tan SM; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Lindblom RSJ; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Ziemann M; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Laskowski A; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Granata C; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia.; Institute for Health and Sport, Victoria University, Melbourne, VIC 3011, Australia., Snelson M; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Thallas-Bonke V; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., El-Osta A; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Baeza-Garza CD; WestCHEM School of Chemistry, University of Glasgow, Glasgow G12 18QQ, UK., Caldwell ST; WestCHEM School of Chemistry, University of Glasgow, Glasgow G12 18QQ, UK., Hartley RC; WestCHEM School of Chemistry, University of Glasgow, Glasgow G12 18QQ, UK., Krieg T; Department of Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0XY, UK., Cooper ME; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia., Murphy MP; Department of Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0XY, UK.; MRC Mitochondrial Biology Unit, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0XY, UK., Coughlan MT; Department of Diabetes, Central Clinical, School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, VIC 3004, Australia.; Baker Heart & Diabetes Institute, Melbourne, VIC 3004, Australia.
Publikováno v:
Nutrients [Nutrients] 2021 Apr 25; Vol. 13 (5). Date of Electronic Publication: 2021 Apr 25.
Autor:
Park M; Department of Medicine, University of Cambridge, Cambridge, UK., Nishimura T; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.; Takeda Pharmaceutical Ltd, Tokyo, Japan., Baeza-Garza CD; WestCHEM School of Chemistry, University of Glasgow, Glasgow, UK., Caldwell ST; WestCHEM School of Chemistry, University of Glasgow, Glasgow, UK., Pun PBL; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Prag HA; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Young T; Department of Medicine, University of Cambridge, Cambridge, UK., Sauchanka O; Department of Medicine, University of Cambridge, Cambridge, UK., Logan A; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Forkink M; Department of Medicine, University of Cambridge, Cambridge, UK., Gruszczyk AV; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Prime TA; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Arndt S; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Naudi A; Department Of Experimental Medicine, University of Lleida, Lleida Institute for Biomedical Research, Lleida, Spain., Pamplona R; Department Of Experimental Medicine, University of Lleida, Lleida Institute for Biomedical Research, Lleida, Spain., Coughlan MT; Department of Diabetes, Monash University, Melbourne, Australia., Tate M; Department of Diabetes, Monash University, Melbourne, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Ritchie RH; Department of Diabetes, Monash University, Melbourne, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Caicci F; Department of Biology, University of Padova, Padua, Italy., Kaludercic N; Neuroscience Institute, National Research Council of Italy (CNR), Pisa, Italy., Di Lisa F; Department of Biomedical Sciences, University of Padova, Padua, Italy., Smith RAJ; Department of Chemistry, University of Otago, Otago, New Zealand., Hartley RC; WestCHEM School of Chemistry, University of Glasgow, Glasgow, UK., Murphy MP; Department of Medicine, University of Cambridge, Cambridge, UK.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK., Krieg T; Department of Medicine, University of Cambridge, Cambridge, UK. tk382@medschl.cam.ac.uk.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2020 Dec; Vol. 34 (6), pp. 823-834. Date of Electronic Publication: 2020 Sep 26.
Autor:
Tate M; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Department of Diabetes, Monash University, Melbourne, VIC, Australia., Higgins GC; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle AlbertiMemorial Centre for Diabetic Complications, Diabetic Complications Division,, Baker Heart and Diabetes Institute, Melbourne, Australia., De Blasio MJ; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Lindblom R; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle AlbertiMemorial Centre for Diabetic Complications, Diabetic Complications Division,, Baker Heart and Diabetes Institute, Melbourne, Australia., Prakoso D; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Deo M; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Kiriazis H; Experimental Cardiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Park M; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK., Baeza-Garza CD; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK., Caldwell ST; WestCHEM School of Chemistry, University of Glasgow, G12 18QQ, Glasgow, UK., Hartley RC; WestCHEM School of Chemistry, University of Glasgow, G12 18QQ, Glasgow, UK., Krieg T; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK., Murphy MP; Department of Medicine, University of Cambridge, Cambridge, Biomedical Campus, Cambridge, UK.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0XY, UK., Coughlan MT; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle AlbertiMemorial Centre for Diabetic Complications, Diabetic Complications Division,, Baker Heart and Diabetes Institute, Melbourne, Australia., Ritchie RH; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. Rebecca.Ritchie@baker.edu.au.; Department of Diabetes, Monash University, Melbourne, VIC, Australia. Rebecca.Ritchie@baker.edu.au.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2020 Apr; Vol. 34 (2), pp. 223.
Autor:
Tate M; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Department of Diabetes, Monash University, Melbourne, VIC, Australia., Higgins GC; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker Heart and Diabetes Institute, Melbourne, Australia., De Blasio MJ; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Lindblom R; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker Heart and Diabetes Institute, Melbourne, Australia., Prakoso D; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Deo M; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Kiriazis H; Experimental Cardiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Park M; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Baeza-Garza CD; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Caldwell ST; WestCHEM School of Chemistry, University of Glasgow, Glasgow, G12 18QQ, UK., Hartley RC; WestCHEM School of Chemistry, University of Glasgow, Glasgow, G12 18QQ, UK., Krieg T; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Murphy MP; Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0XY, UK., Coughlan MT; Department of Diabetes, Monash University, Melbourne, VIC, Australia.; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker Heart and Diabetes Institute, Melbourne, Australia., Ritchie RH; Heart Failure Pharmacology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. Rebecca.Ritchie@baker.edu.au.; Department of Diabetes, Monash University, Melbourne, VIC, Australia. Rebecca.Ritchie@baker.edu.au.
Publikováno v:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2019 Dec; Vol. 33 (6), pp. 669-674.
Autor:
Arndt S; From the MRC Mitochondrial Biology Unit, University of Cambridge, Hills Road, Cambridge CB2 0XY, United Kingdom., Baeza-Garza CD; the WestCHEM School of Chemistry, University of Glasgow, Glasgow G12 8QQ, United Kingdom., Logan A; From the MRC Mitochondrial Biology Unit, University of Cambridge, Hills Road, Cambridge CB2 0XY, United Kingdom., Rosa T; the Department of Medicine, University of Cambridge, Biomedical Campus, Cambridge, CB2 2QQ, United Kingdom., Wedmann R; the Department of Chemistry and Pharmacy, Friedrich-Alexander University of Erlangen-Nuremberg, Egerlandstrasse,1, 91058 Erlangen, Germany., Prime TA; From the MRC Mitochondrial Biology Unit, University of Cambridge, Hills Road, Cambridge CB2 0XY, United Kingdom., Martin JL; the Department of Surgery and Cambridge NIHR Biomedical Research Centre, Biomedical Campus, University of Cambridge, Cambridge CB2 2QQ, United Kingdom., Saeb-Parsy K; the Department of Surgery and Cambridge NIHR Biomedical Research Centre, Biomedical Campus, University of Cambridge, Cambridge CB2 2QQ, United Kingdom., Krieg T; the Department of Medicine, University of Cambridge, Biomedical Campus, Cambridge, CB2 2QQ, United Kingdom., Filipovic MR; the Department of Chemistry and Pharmacy, Friedrich-Alexander University of Erlangen-Nuremberg, Egerlandstrasse,1, 91058 Erlangen, Germany.; the University of Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France, and., Hartley RC; the WestCHEM School of Chemistry, University of Glasgow, Glasgow G12 8QQ, United Kingdom, Richard.Hartley@glasgow.ac.uk., Murphy MP; From the MRC Mitochondrial Biology Unit, University of Cambridge, Hills Road, Cambridge CB2 0XY, United Kingdom, mpm@mrc-mbu.cam.ac.uk.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2017 May 12; Vol. 292 (19), pp. 7761-7773. Date of Electronic Publication: 2017 Mar 20.